LeonaBio
1 known investors
Find your way into LeonaBio
408 people in our graph share verified history with the LeonaBio team — schools, employers, funds. One of them is your warm intro.
Howardunlockedknows Mark Litton · together at Santa Clara University Leavey School of Business
×3knows the team · via Stockholm University
×6knows the team · via UC Santa Cruz
×2knows the team · via Santa Clara University Leavey School of Business
LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The company targets patients with diseases that have significant unmet medical needs.
Founders & leadership
ML
Mark LittoninPresident and CEOMark Litton is president and CEO of LeonaBio, which develops therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. He has held leadership and strategy roles across biotechnology for over two decades and serves on the boards of Athira Pharma and Lumen Bioscience.
Investors · 1
Frequently asked questions
- What does LeonaBio do?
- LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). The company targets patients with diseases that have significant unmet medical needs.
- Who are LeonaBio's investors?
- LeonaBio's investors include New Enterprise Associates (NEA).